STOCK Act disclosures
TBPH Theravance Biopharma, Inc.
Members of Congress who traded or hold Theravance Biopharma, Inc., from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. TBPH earnings.
- 1 members traded it since Nov 22, 2023
- 0 / 1 buys / sales
- 0 held it at year end
- Mar 24, 2025 latest trade
Trades
1 trade since Nov 22, 2023, newest filings first
-
TBPHTheravance Biopharma, Inc. - Ordinary SharesSell$15K–$50KTraded Mar 24, 2025Filed Apr 23, 2025 30d
No trades match these filters.
Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.